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Abstract
Background: Until recently, few genomic reagents specific for non-human primate research have been available.
To address this need, we have constructed a macaque-specific high-density oligonucleotide microarray by using
highly fragmented low-pass sequence contigs from the rhesus genome project together with the detailed sequence
and exon structure of the human genome. Using this method, we designed oligonucleotide probes to over 17,000
distinct rhesus/human gene orthologs and increased by four-fold the number of available genes relative to our first-
generation expressed sequence tag (EST)-derived array.
Results: We constructed a database containing 248,000 exon sequences from 23,000 human RefSeq genes and
compared each human exon with its best matching sequence in the January 2005 version of the rhesus genome
project list of 486,000 DNA contigs. Best matching rhesus exon sequences for each of the 23,000 human genes
were then concatenated in the proper order and orientation to produce a rhesus "virtual transcriptome."
Microarray probes were designed, one per gene, to the region closest to the 3' untranslated region (UTR) of each
rhesus virtual transcript. Each probe was compared to a composite rhesus/human transcript database to test for
cross-hybridization potential yielding a final probe set representing 18,296 rhesus/human gene orthologs, including
transcript variants, and over 17,000 distinct genes. We hybridized mRNA from rhesus brain and spleen to both the
EST- and genome-derived microarrays. Besides four-fold greater gene coverage, the genome-derived array also
showed greater mean signal intensities for genes present on both arrays. Genome-derived probes showed 99.4%
identity when compared to 4,767 rhesus GenBank sequence tag site (STS) sequences indicating that early stage low-
pass versions of complex genomes are of sufficient quality to yield valuable functional genomic information when
combined with finished genome information from a closely related species.
Conclusion: The number of different genes represented on microarrays for unfinished genomes can be greatly
increased by matching known gene transcript annotations from a closely related species with sequence data from
the unfinished genome. Signal intensity on both EST- and genome-derived arrays was highly correlated with probe
distance from the 3' UTR, information often missing from ESTs yet present in early-stage genome projects.
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Background
The rhesus macaque (Macaca mulatta) serves as a model
for many facets of human development and physiology
and is one of the most widely used nonhuman primates
for the study of infectious diseases, such as AIDS. The
widespread use of this species in biomedical research led
to a proposal in 2002 to generate its complete genome
sequence [1]. This proposal was followed up by low-pass
whole-genome shotgun (WGS) sequencing of rhesus in
2004 and the completion of a preliminary draft of the
genome in January 2005 [2]. The importance of rhesus
and related macaque species as experimental animals has
prompted us to use the genome sequence to develop a
macaque-specific microarray to provide the requisite tools
for global gene expression profiling and functional
genomic analyses.
Until recently, we and others have been limited to using
human sequence based microarrays for experiments
aimed at analyzing gene expression in rhesus and other
macaque species [3-10]. Although not optimal, this
approach is feasible because of the relatively close evolu-
tionary distance between the two species. Rhesus and
human species diverged approximately 25 million years
ago, and the nucleotide similarity between rhesus and
human is estimated at 95% [11]. Despite this similarity,
nucleotide mismatches between the species can confound
expression analysis on commonly used microarray plat-
forms. For example, experiments using mixed-species
cDNA microarrays required raising expression fold-
change thresholds to a level that limited the number of
genes whose expression can be confidently measured
[12]. Similarly, an Affymetrix GeneChip analysis measur-
ing presence of gene expression by hybridizing rhesus
mRNA on human chips required twice the signal intensity
for Affymetrix analysis software to indicate gene presence
compared with using human mRNA, rendering many
human GeneChip probe sets unusable when analyzing
rhesus samples [13]. In silico approaches have also been
used to try to improve the reliability of using human
probe sets to study cross-species gene expression by infor-
matically "masking" probes that show excessive cross-spe-
cies nucleotide probe mismatching [14,15]. Even single
base-pair mismatches occurring on Agilent 60-mer oligo-
nucleotide microarrays may result in as much as a 50%
drop in test/reference signal intensity if the mismatches
fall in the 5' region of the oligonucleotide probe [16].
We previously reported on the use of macaque EST
sequences to develop the first commercially available two-
color oligonucleotide rhesus-specific microarray, Katze
Rhesus Macaque 1 (KRM1) [11]. Over 36,000 EST
sequences from eleven rhesus tissues were used for probe
design. KRM1 gene coverage represented only 3,500 dis-
tinct rhesus/human RefSeq [17] orthologs out of a possi-
ble 23,000, largely due to the redundancy that is
characteristic of tissue-specific EST libraries as well as dif-
ficulties in achieving effective mRNA transcript coverage
of unique EST contigs for probe design. To supplement
the EST-derived gene list, an additional 500 RefSeq gene
probes on the microarray were designed from sequence
tag site (STS) sequences generated by leveraging human
transcript and genomic information [18], and approxi-
mately 1,000 human probes were added to the array from
the Agilent Human HA1v2 microarray to include
sequences important in virus-host interaction pathways.
EST sequence assemblies often did not extend to the 3'
untranslated region (UTR) of an orthologous human
gene, rendering probe design regions proximal to the 3'
edge of genes unavailable. Due to 3' labeling bias, Agilent
Technologies recommends designing probes within 800
bp of the 3' end of a gene transcript [Nelson personal
communications]. Figure 1 shows the effect of probe dis-
tance from the terminal exon 3' UTR for our KRM1 EST-
based array. Probe sequences more than 400 bp from the
3' end of the human gene ortholog showed a dramatic
attenuation of signal intensity with the best hybridization
signals occurring closest to the 3' end of the gene.
For the above reasons, there was clearly a need for an alter-
native to our EST-based array to provide better coverage of
rhesus/human gene orthologs and to optimize probe
selection regions to include genomic regions proximal to
the 3' end of gene transcripts. In the present study, we
employed a human/rhesus comparative genomics
approach to address these issues, using human genome
sequence and annotation to derive optimal probe design
regions from an unfinished and highly fragmented build
of the rhesus genome sequence. This approach greatly
increased the number of genes available for expression
Average binned signal channel intensities for 60-mer oligonu- cleotide probes increase with proximity to the 3' UTR of  gene transcripts Figure 1
Average binned signal channel intensities for 60-mer oligonu-
cleotide probes increase with proximity to the 3' UTR of 
gene transcripts.
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analysis and optimized hybridization signal intensities.
These results show that early stage genome projects are a
valuable source of information that can be immediately
utilized for functional genomics assays.
Results and discussion
Earlier studies report that the terminal exon of human
transcripts, which contains the optimal 3' UTR microarray
probe design region, averages almost 1,400 bp with a
median length of 1,000 bp [18]. If probe hybridization
efficiency is related to the distance of a probe from the 3'
UTR, it means that the great majority of all optimal micro-
array probe design regions fall within the terminal exon of
human genes. We tested the conservation of rhesus/
human 3' UTRs by first deconstructing the human
genome into its constituent exons. We extracted sequence
data for each exon from the May 2004 build of the human
genome using RefSeq version 11 exon coordinates for
22,975 genes provided by the UCSC genome browser
annotation [19]. These 248,000 exon sequences, and their
predicted exon order and orientation for each gene, were
used to construct a human RefSeq exon sequence data-
base. We found a mean length of 1,233 bp for the termi-
nal exon and 3' UTR of RefSeq genes including single-
exon genes and excluding genes with unassigned chromo-
somal locations. Terminal exon lengths ranged from 14
bp up to a maximum exon length of 12,800 bp with a
median length of 916 bp.
We matched human genome transcript information to
rhesus unfinished contigs by initially comparing 22,975
terminal exon sequences derived from RefSeq with
486,000 Baylor rhesus genome project version 0.1 WGS
contigs averaging 5,540 bp in length, excluding rhesus
assemblies containing highly repetitive elements.
Remarkably, we were able to match 22,797 out of the
22,975 human terminal exon sequences (99%) to the
unfinished rhesus genome sequence, including 17,702
out of 17,934 (99%) distinct rhesus/human RefSeq gene
orthologs. Mean alignment size was approximately 1,100
bp covering greater than 90% of each human terminal
exon. Human terminal exon sequences matched rhesus
contigs with a 94.4% mean identity.
Rhesus microarray design and probe quality assessment
Microarray design requires comparing all individual
probes with all transcriptome sequences to exclude probes
highly similar to more than one location in the transcrip-
tome and therefore subject to non-specific mRNA cross-
hybridization [20]. To address this, we created a "virtual"
rhesus transcriptome by aligning 224,000 non-terminal
human RefSeq exons with the same 486,000 rhesus WGS
contigs used to determine the probe design regions
described above. Again, we were able to align non-termi-
nal exons for over 99% of human RefSeq genes with a
mean alignment size of 154 bp and a human/rhesus
96.5% mean identity. Best matching human/rhesus exon
sequences were concatenated in order and orientation
based on the human transcript information to create a vir-
tual rhesus transcriptome to test probe regions for cross-
hybridization potential. To guard against missing pieces
of the early stage WGS genome, we created a more con-
servative composite rhesus/human transcriptome data-
base, which we used to test for cross-hybridization. Probes
were designed and arrayed at Agilent Technologies result-
ing in 18,296 rhesus/human RefSeq ortholog gene
probes, including transcript variants, which represent over
17,000 distinct genes. These 18,296 rhesus genome-
derived probes were included in the final array layout,
with one probe per gene. The new 22,500-probe custom
rhesus array, Katze Rhesus Macaque 2 (KRM2), is com-
mercially available from Agilent Technologies [21], Agi-
lent Microarray Design Identification (AMADID) Number
013791. Affymetrix Corporation has also recently devel-
oped a commercial rhesus-specific microarray based on
the November, 2004 version of the Baylor rhesus genome
project along with GenBank rhesus EST, STS and mRNA
sequences up to March 30, 2005 [22].
We tested the similarity of the KRM2 genome-derived
probes to other available rhesus sequences to gauge the
quality of WGS contigs used in probe design. We searched
each KRM2 probe against a BLAST database of 4,767 high-
quality GenBank STS sequences derived from rhesus PCR
products designed specifically to 3' UTR regions [18]. We
found that 3,977 KRM2 60-mer probes matched rhesus
STS sequences with a mean similarity of 99.4%, demon-
strating high sequence quality in 3' UTR probe design
regions despite the overall low 3.5× genome coverage (R.
A. Gibbs personal communications) in the January 2005
build of the rhesus genome.
Distance of probes from transcript 3' UTRs
Figure 2 displays the distribution of microarray probes in
relation to the distance from the 3' UTR for all transcripts
present on both the KRM1 and KRM2 arrays. KRM1 60-
mers showed a mean distance of 1,084 bp from the 3' UTR
of their rhesus/human transcript ortholog genes when
BLAST searched, whereas KRM2 probes averaged less than
400 bp, with half of the probes falling less than 200 bp
from the predicted end of the orthologous transcript.
Comparison of KRM1 and KRM2 rhesus arrays
We tested the KRM2 microarray by hybridizing cRNA
probes generated from equal mass amounts of mRNA
derived from rhesus brain and spleen (hybridized in two
channels with an experimental n = 4). The same probes
were also used to replicate the experiment on our EST-
based KRM1 microarray. Brain and spleen tissues were
chosen for the experiment to maximize potential differen-BMC Genomics 2007, 8:28 http://www.biomedcentral.com/1471-2164/8/28
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tial expression of KRM1 probes, which were mainly
designed using rhesus brain and spleen tissue EST
sequences. A minimum two-fold difference in test/refer-
ence channel signal intensity and a maximum P value of
0.01 were selected as cut offs to indicate differential gene
expression for individual probes.
Using these criteria, 1,463 genes showed differential
expression on the KRM1 microarray, compared with
4,826 genes showing differential expression on the KRM2
microarray. Although the number of differentially
expressed genes will obviously change according to exper-
imental samples and treatments, this helps demonstrate
the effect of the four-fold increase in the number of
unique genes available on the KRM2 array. In addition,
60-mer probes for 2,650 human RefSeq gene orthologs
are common to both the KRM1 and KRM2 arrays, which
allowed us to compare cy3/cy5 signal channel and fold-
change measurements for each of these probes.
When we compared 2,650 genes present on both the
KRM1 and KRM2 arrays, 1,085 genes were differentially
expressed on the KRM2 array versus 841 differentially
expressed genes on KRM1, a 22% improvement using the
new array. Of the 841 genes differentially expressed on
KRM1 732 of the identical genes (87%) showed differen-
tial expression on the KRM2 array. The greater number of
differentially expressed genes on KRM2 versus KRM1 for
genes represented on both arrays suggests a distinct
improvement in probe performance using genomic versus
EST based array probe design. Despite this improvement,
overlap in expression results between identical genes on
KRM2 and KRM1 is, as expected, not perfect, and microar-
ray results will continue to be used, by our lab and others,
as part of a discovery process requiring individual gene
verification by methods such as RT-PCR. Hybridization
results for all rhesus probes for both arrays in the above
experiment are given in supplemental Tables 1 and 2 [see
Additional files 1 and 2].
The results of the brain versus spleen hybridizations high-
light the extra coverage garnered in the KRM2 array. Figure
3 shows genes differentially expressed between the two
tissue sets in the GABA receptor signaling and antigen
presentation pathways, as determined using Ingenuity
Pathway Analysis software [23]. As expected, the cluster of
GABA receptor signaling genes was more highly expressed
in the brain tissue, whereas the cluster corresponding to
antigen presentation was expressed at higher levels in
spleen. We saw a 40% better representation of genes in the
antigen presentation pathway using the KRM2 array, and
a 100% increase in representation of the genes in the
GABA pathway. This is of particular interest since one of
the macaque EST libraries that we sequenced to design the
KRM1 array was brain derived. Although our EST
sequences did contain data for 5 of the 9 GABA-related
genes, sufficient sequence data for probe design was avail-
able for only three of these genes (GABRA2, GABRB1, and
UBQLN1). It is therefore clear that use of the early stage
genome information provides better sequence informa-
tion for probe design as well as a greater depth of coverage
in terms of overall numbers of genes.
Conclusion
One of the greatest benefits of utilizing early stage genome
information in conjunction with closely related species
annotation in oligonucleotide microarray design is the
huge increase in the number of different genes available
for mRNA abundance measurements compared with rely-
ing on EST sequence data alone. This increased number of
genes in turn helps provide more comprehensive input for
pathway and network analysis of differential gene expres-
sion. Figure 4 shows the average coverage per pathway,
where at least one gene is present, for 540 pathway maps
represented in GeneGo's MetaCore[24] database for genes
available on KRM2 and KRM1 arrays.
The relationship between signal intensity and probe dis-
tance from the 3' UTR was much more dramatic than
expected and a factor to be seriously considered in micro-
array probe design as well as microarray analysis. The
apparent reason for this bias appears to relate to the effi-
ciency of the reverse transcriptase reaction.
Historically, full-length cDNA transcripts have been chal-
lenging to achieve, with most first-strand synthesis reac-
tions resulting in pools of transcripts in the 400 bp to 1.5
Genome-based rhesus probes on microarray KRM2 are  closer to the 3' UTR of gene transcripts compared with rhe- sus EST-based probes on the KRM1 microarray Figure 2
Genome-based rhesus probes on microarray KRM2 are 
closer to the 3' UTR of gene transcripts compared with rhe-
sus EST-based probes on the KRM1 microarray.
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Comparison of gene coverage between KRM1 and KRM2 for GABA receptor signaling (brain-centric) and antigen presentation  (spleen-centric) pathways highlights greater coverage and specificity of probes on the KRM2 array designed from genomic data Figure 3
Comparison of gene coverage between KRM1 and KRM2 for GABA receptor signaling (brain-centric) and antigen presentation 
(spleen-centric) pathways highlights greater coverage and specificity of probes on the KRM2 array designed from genomic data. 
These networks are laid out with the KRM1 results on top and the KRM2 below. Genes indicated in yellow were more prom-
inently expressed in spleen while the blue denotes higher expression levels in brain. The antigen presentation network (in yel-
low) shows a 66% greater coverage on the KRM2 array, while the GABA receptor signaling network (in blue) is completely 
void on KRM1 and fully covered on KRM2.BMC Genomics 2007, 8:28 http://www.biomedcentral.com/1471-2164/8/28
Page 6 of 10
(page number not for citation purposes)
Kbp range. Premature terminations of the reaction fre-
quently occur due to secondary and tertiary structures in
the transcript, and increased product size is often associ-
ated with increases in single-base errors in the sequence
[25]. Due to the nature of the reverse transcriptase reac-
tion, the 3' region of the transcript is therefore the best tar-
get for probe design considering its greater likelihood of
being transcribed accurately and completely. This may be
particularly significant when designing probes for tran-
script variants where alternative exons require probes dis-
tal to the end of the gene transcript. The distance of the
probe from the 3' UTR may also greatly outweigh other
factors such as probe/mRNA mismatching, so that mRNA
samples from closely related macaque species including
M. nemestrina and M. fascicularis, can also be used for gene
expression analysis on the rhesus genome-based KRM2
microarray. 18,296 KRM2 rhesus probes compared with
M. nemestrina and M. fascicularis EST sequences showed a
greater than 98% similarity to both species, representing
on average a single base mismatch per 60-mer probe.
Although there are many advantages in leveraging anno-
tations from closely related species to design microarray
probes from genomic sequences, there are obvious limita-
tions to this method. Gene isoforms, including splice var-
iants, are restricted to those mapped from the related
species annotation; true splice variant information still
has to be obtained by other methods, such as cDNA
sequencing from different tissues from the microarray tar-
get species. Species-specific genes are also not addressed
using this method. Important innate immunity genes,
such as theta-defensins, are only expressed in Old World
monkeys such as rhesus macaque [26], whereas the adap-
tive immune system HLA-C loci present in humans is
missing in macaques [27].
In addition to designing rhesus probes using human
genome annotations, we will also continue to use species-
specific cDNA-derived probes on future macaque microar-
rays, particularly in light of the growth of the number of
macaque ESTs and full-length mRNA transcripts available
in public databases. Currently, almost 1,000 EST-derived
probes were carried over from KRM1 onto the new KRM2
microarray. Ultimately, microarray probes derived from
macaque-specific unannotated assemblies may be the
most interesting of all, since they offer the greatest poten-
tial for discovering new genes and gene expression path-
ways [28].
Methods
Bioinformatics pipeline
Figure 5 shows bioinformatics components used in array
design. Human genome build 34, NCBI RefSeq version
11, and the January 2005 Baylor rhesus build 0.1 genome
were used as the reference databases for all analyses. NCBI
BLAST for LINUX version 2.2.1 [29] was used for all
BLAST searches conducted on four Intel dual-processor
computer systems. CLUSTALW [30] version 1.83 was used
for secondary alignment of human/rhesus exon high-scor-
ing segment pair regions using default CLUSTALW DNA
sequence alignment parameters. BLAST and CLUSTALW
parsing, comparisons, and database loading routines were
written using Java JDK version 1.4 (Sun Microsystems).
MySQL version 4.1 for Microsoft Windows Professional
[31] was used as the relational database to store all
sequence and analysis information.
A MySQL database table was constructed to store 248,000
NCBI RefSeq exon sequences and exon positions for
23,000 human RefSeq genes. Each human exon sequence
was searched using BLASTN against a database of 486,600
Baylor rhesus genome contigs with BLAST parameters of b
= 1, v = 1 and expected value of 10-4. Human/rhesus High
Scoring Pairs (HSPs) for the best matching rhesus contig
for each exon were parsed from BLAST output and stored
in an exon alignment table. This table was used as input
to a Java script to determine the mapping between
BLASTN human exon HSPs and the best matching rhesus
genome contig for each human exon. The longest match-
Average coverage per pathway, where at least one gene is  present, for the 540 pathway maps represented in GeneGo's  MetaCore database Figure 4
Average coverage per pathway, where at least one gene is 
present, for the 540 pathway maps represented in GeneGo's 
MetaCore database.
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KRM2 rhesus macaque microarray bioinformatics pipeline Figure 5
KRM2 rhesus macaque microarray bioinformatics pipeline.
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ing rhesus HSP was used to establish the initial probe tar-
get alignment region between each human exon and the
best matching rhesus contig. Additional rhesus HSPs were
used to extend the alignment region upstream and down-
stream from the initial alignment until all HSPs were
used. Once a rhesus contig alignment region was estab-
lished, the DNA sequence for this region was used to pro-
duce a full-length alignment with its corresponding
human exon DNA sequence using CLUSTALW. Ungapped
full-length rhesus genome DNA alignment regions for
each gene were then handed off to the probe design proc-
ess as probe design target sequence candidates. Terminal
exons were used whenever possible for probe design due
to their proximity to the 3' end of a gene and because they
do not cross intron/exon DNA sequence boundaries. A
gzipped fasta file of rhesus DNA alignment regions match-
ing terminal exons for 22,797 human RefSeq genes pro-
duced by the bioinformatics pipeline using the above
process is provided in Additional File 3.
Probes were designed using the commercial probe design
process and associated algorithms of Agilent Technolo-
gies, Inc. As part of this process, all replicate target
sequences were removed along with sequences that were
too short for probe design. Target sequences were then
vector masked using an Agilent-modified version of the
Univec database [32] in conjunction with a BLAST-like
algorithm and masking scripts. Target sequences were also
repeat masked using RepeatMasker and the primate repeat
database obtained from Repbase [33]. A set of candidate
probes were selected for each target sequence; choosing
those that resided within 800 bp from the sequence's 3'
end, in addition to matching an optimal base composi-
tion profile. This empirically-determined profile defines
an appropriate ratio of nucleic acid sequences (A, T, C, G)
to perform optimally on Agilent's in situ oligonucleotide
microarray platform. Final probes were selected from the
candidate set based upon duplex formation stability and
cross-hybridization potential with a defined transcrip-
tome database.
A probe design file was created to distribute the probes
randomly on an Agilent 22K-featured microarray. The
final array design (AMADID# 013791) is available for
review and download free of charge for registered users of
the Agilent eArray application [34]. A complete list of
KRM2 gene names, 60-mer rhesus DNA probe sequences
and base pair distances from the 3' UTR of corresponding
human RefSeq gene transcripts is included in supplemen-
tal Table 3 [see Additional file 4].
Tissue processing
Spleen and brain tissues were collected at necropsy from
healthy adult rhesus macaques and immersed immedi-
ately in RNAlater (Ambion Inc.) to preserve the quality of
RNA.
Brain tissue was pooled from cerebreum and cerebellum
from two macaque females and spleen tissue was pooled
from four macaque females and one macaque male.
Tissue samples were then homogenized with Solution D
(4 M guanidinium thiocyanate, 25 mM sodium citrate,
0.5% sarcosyl, 0.1 M β-mercaptoethanol). Homogeniza-
tion with a Kinematica Polytron PT1200 instrument and
the model PT-DA1212/2 generator (Kinematica, Switzer-
land) lasted for 30 seconds in 10 ml round-bottom poly-
propylene test tubes with 5 ml of solution D. In order to
reduce generation of aerosols during this process, the pol-
ytron's generator was passed through a hole in the test
tube lid that had been drilled in a manner that ensured a
tight fit with the instrument. To further minimize possible
contact with aerosols, a barrier shield was used in addi-
tion to positive air pressure respirators and full protective
personal protection equipment. Total RNA was subse-
quently extracted using RNeasy columns (Qiagen) and the
quality and quantity of the total RNA was determined by
using a Nanodrop spectrophotometer (Nanodrop Tech-
nologies) and the Bionalyzer 2100 system (Agilent Tech-
nologies).
Oligonucleotide microarray hybridization and analysis
Samples of both the spleen and brain tissues were pooled
using equal amounts of total RNA. cRNA target produc-
tion was done with the Agilent Low RNA Input Fluores-
cent Linear Amplification kit (Agilent Technologies).
Slides were scanned with an Agilent DNA microarray
scanner, and image analysis was performed using Agilent
Feature Extractor Software. Each microarray experiment
was done with two technical replicates by reversing dye
hybridization for experimental and reference samples. All
data were entered into a custom-designed database,
Expression Array Manager [35], and then uploaded into
Resolver 5.0 (Rosetta Biosoftware), DecisionSite for Func-
tional Genomics (Spotfire, Inc.), and Ingenuity Pathway
Analysis (Ingenuity Systems) for analysis and mining.
Genes were selected to be included for transcriptional pro-
file based on two criteria: a greater than 99% probability
of being differentially expressed (P ≤ 0.01) and an expres-
sion level change of 2 fold or greater. Finally, biological
gene sets (referred to as Biosets) were compiled for key cel-
lular processes by selecting genes of interest that were
both represented on the microarray and which had Gene
Ontology (GO) annotation. In accordance with proposed
standards [36], all data described in this report, including
sample information, intensity measurements, gene lists,
error analysis, microarray content, and slide hybridization
conditions, are available in the public domain through
Expression Array Manager [35]. Microarray raw data are
available at the European Bioinformatics Institute (EBI)
ArrayExpress database [37] accession number E-TABM-
189.BMC Genomics 2007, 8:28 http://www.biomedcentral.com/1471-2164/8/28
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